CN Stock MarketDetailed Quotes

002873 Guiyang Xintian Pharmaceutical

Watchlist
  • 10.86
  • +0.27+2.55%
Not Open Dec 12 15:00 CST
2.45BMarket Cap45.25P/E (TTM)

Guiyang Xintian Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-33.17%136.72M
-42.84%73.19M
20.57%140.61M
37.32%138.24M
127.52%204.57M
0.31%128.04M
-19.22%116.61M
38.89%100.67M
-8.52%89.91M
-59.60%127.64M
Transactional financial assets
10.75%104.48K
-2.51%98.39K
4.86%110.06K
-15.45%94.34K
--94.34K
-99.33%100.93K
--104.96K
-99.86%111.58K
----
-25.00%15M
Notes receivable and accounts receivable
11.87%326.52M
-9.30%298.16M
-6.06%221.15M
-4.03%240.36M
-13.38%291.87M
27.60%328.72M
4.41%235.41M
5.88%250.46M
23.95%336.95M
14.97%257.62M
-Notes receivable
-62.97%5.36M
-59.20%4.64M
-35.68%7.35M
-20.37%13.91M
-34.44%14.46M
-25.61%11.36M
59.11%11.43M
26.91%17.47M
33.66%22.06M
-8.98%15.27M
-Accounts receivable
15.78%321.17M
-7.51%293.52M
-4.54%213.8M
-2.81%226.45M
-11.90%277.41M
30.95%317.36M
2.61%223.98M
4.58%232.99M
23.32%314.89M
16.90%242.35M
Other receivables (including interest and dividends)
-52.34%35.41M
-1.47%36.41M
-2.95%52.7M
11.51%46.6M
152.20%74.3M
42.57%36.96M
53.50%54.3M
106.37%41.79M
52.00%29.46M
58.45%25.92M
-Other receivable
----
-1.47%36.41M
----
----
----
42.57%36.96M
----
--41.79M
----
58.45%25.92M
Advance payment
-71.86%3.39M
-53.20%6.01M
-43.50%7.46M
-36.68%9.6M
-16.73%12.03M
5.40%12.84M
4.51%13.21M
33.98%15.16M
28.35%14.45M
30.62%12.18M
Inventories
-12.54%148.97M
-7.39%165.09M
-8.76%192.23M
0.54%184.33M
13.45%170.33M
6.66%178.26M
36.35%210.69M
54.37%183.34M
64.04%150.13M
62.10%167.14M
Receivable financing
-56.07%8.27M
-51.54%4.76M
--3.65M
-11.50%10.18M
30.21%18.83M
2.90%9.83M
--0
-75.09%11.5M
-52.81%14.46M
-68.65%9.55M
Other current assets
33.99%2.8M
-54.35%2.1M
-32.27%5.72M
-7.75%7.02M
1,401.25%2.09M
1,201.12%4.59M
42.85%8.45M
489.11%7.61M
-82.00%139.31K
-77.03%353.06K
Total current assets
-14.46%662.18M
-16.23%585.83M
-2.37%623.64M
4.22%636.43M
21.81%774.11M
13.64%699.34M
6.07%638.78M
4.06%610.65M
-2.78%635.5M
-14.62%615.4M
Non Current assets
Other equity investment
-16.96%383.25M
-16.96%383.25M
-16.96%383.25M
-16.96%383.25M
47.69%461.55M
47.69%461.55M
47.69%461.55M
47.69%461.55M
-6.34%312.5M
23.20%312.5M
Other non-current financial assets
-5.17%23.57K
-5.17%23.57K
-7.18%23.57K
-7.18%23.57K
--24.85K
--24.85K
--25.39K
--25.39K
----
----
Investment real estate
-2.67%3.43M
-2.65%3.46M
-2.64%3.48M
-2.62%3.5M
-2.60%3.53M
-32.63%3.55M
-2.81%3.58M
-2.88%3.6M
-2.95%3.62M
40.24%5.27M
Fixed assets
----
80.40%651.31M
----
----
----
-0.73%361.03M
----
--357.81M
----
18.18%363.7M
Constru in process
----
-80.82%52.32M
----
----
----
75.05%272.82M
----
--228.36M
----
81.48%155.85M
Intangible assets
-2.86%81.05M
-2.68%81.96M
-2.89%82.68M
-3.00%83.52M
-3.87%83.44M
-2.04%84.22M
-1.81%85.13M
-1.61%86.1M
-1.57%86.79M
-3.42%85.97M
Development expenditure
24.52%96.96M
22.97%91.11M
30.40%90.58M
29.31%81.52M
28.77%77.87M
31.97%74.1M
30.65%69.46M
25.64%63.05M
23.95%60.47M
23.85%56.15M
Long deferred expense
-21.54%5.71M
-12.36%6.12M
-7.03%6.52M
-5.69%6.92M
-5.04%7.28M
-11.26%6.98M
-14.29%7.01M
-13.58%7.34M
-14.18%7.67M
-16.42%7.87M
Deferred tax assets
-16.54%10.94M
-32.34%10.65M
-28.74%11.21M
-23.27%10.33M
7.44%13.11M
26.00%15.74M
37.85%15.74M
19.53%13.46M
7.53%12.2M
9.71%12.49M
Usufruct assets
40.62%13.57M
119.81%14.8M
76.96%12.66M
81.08%13.72M
66.52%9.65M
11.37%6.73M
13.33%7.15M
15.14%7.57M
-15.33%5.79M
-14.95%6.05M
Total non current assets
0.26%1.3B
0.64%1.3B
1.21%1.28B
3.78%1.28B
28.61%1.3B
27.93%1.29B
28.14%1.26B
31.07%1.23B
12.19%1.01B
23.68%1.01B
Total assets
-5.24%1.96B
-5.30%1.88B
0.00%1.9B
3.93%1.91B
25.99%2.07B
22.50%1.99B
19.77%1.9B
20.67%1.84B
5.89%1.64B
5.68%1.62B
Liabilities
Current liabilities
Short term loan
4.39%452M
23.28%479.43M
27.13%480M
15.62%366.93M
68.48%433M
37.77%388.9M
22.58%377.55M
18.27%317.37M
-10.76%257M
-12.30%282.27M
Notes payable and accounts payable
-18.43%72.23M
-11.96%73.27M
-8.00%80.38M
9.84%105.08M
40.74%88.55M
14.98%83.21M
7.61%87.37M
47.42%95.67M
15.40%62.92M
26.69%72.37M
-Notes payable
----
----
----
----
--8.11M
--8.11M
----
----
----
----
-Accounts payable
-10.21%72.23M
-2.45%73.27M
-8.00%80.38M
9.84%105.08M
27.85%80.44M
3.77%75.1M
7.61%87.37M
47.42%95.67M
15.40%62.92M
26.69%72.37M
Contract liabilities
-83.67%543.97K
-90.95%892.19K
-94.89%489.93K
-92.78%1M
-68.64%3.33M
261.69%9.86M
482.43%9.59M
-9.76%13.86M
-1.64%10.62M
-63.71%2.73M
Salaries payable
0.79%14.08M
8.36%11.38M
80.05%10.43M
-29.83%12.43M
20.11%13.97M
1.01%10.51M
-51.28%5.79M
3.26%17.71M
9.98%11.63M
-5.55%10.4M
Taxs payable
3.17%25.95M
24.47%24.37M
-4.16%12.61M
0.17%8.89M
2.71%25.15M
17.19%19.58M
-31.59%13.15M
-54.67%8.87M
25.27%24.49M
35.10%16.71M
Other payable (including interest and dividends)
-51.29%11.23M
-49.43%16.25M
6.64%29.92M
-21.99%30.79M
-67.08%23.06M
-62.20%32.12M
-41.15%28.05M
-32.25%39.47M
4.06%70.04M
25.25%84.99M
-Dividend payable
----
----
----
----
----
----
----
----
----
41.90%19.89M
-Other payable
----
-49.43%16.25M
----
----
----
-50.65%32.12M
----
--39.47M
----
20.91%65.1M
Non current liabilities due within one year
2.89%32.43M
25.67%33.36M
509.11%30.46M
371.28%30.18M
--31.51M
--26.55M
--5M
--6.4M
----
----
Other current liabilities
65.47%70.72K
-6.99%115.99K
-88.19%264.95K
-94.45%130.13K
401.34%42.74K
-49.77%124.7K
4,210.30%2.24M
572.16%2.34M
-94.34%8.52K
-76.88%248.27K
Total current liabilities
-1.63%608.53M
11.95%639.06M
21.90%644.54M
10.71%555.42M
41.66%618.62M
21.53%570.85M
12.58%528.75M
13.01%501.69M
-3.67%436.7M
-2.40%469.72M
Current liabilities
Long term loan
96.34%109.95M
-53.39%28M
160.00%52M
159.99%52.06M
124.00%56M
140.01%60.07M
300.00%20M
299.97%20.02M
84.90%25M
79.83%25.03M
Bonds payable
3.12%148.89M
3.19%147.17M
3.32%143.13M
5.00%143.48M
6.70%144.39M
6.45%142.62M
4.31%138.53M
-8.77%136.66M
-9.70%135.32M
-9.65%133.98M
Long term account payable
----
-83.06%562.7K
----
----
----
-1.42%3.32M
----
--3.36M
----
-2.10%3.37M
Deferred tax liabilities
-38.32%17.58M
-38.34%17.39M
-33.38%18.7M
-40.24%16.72M
458.93%28.49M
463.20%28.2M
731.78%28.08M
729.21%27.99M
-22.13%5.1M
-23.52%5.01M
Long term deferred income
10.63%23.49M
14.29%23.85M
-5.76%20.27M
-5.93%20.83M
-5.65%21.23M
-9.87%20.87M
-9.85%21.51M
-9.65%22.15M
-16.70%22.5M
-15.43%23.15M
Lease liabilities
6.76%7.84M
84.23%9.12M
15.70%7.9M
63.52%9.35M
21.42%7.34M
-20.72%4.95M
5.87%6.83M
-13.99%5.72M
-11.59%6.05M
-11.15%6.24M
Total non current liabilities
19.47%308.3M
-13.05%226.09M
11.13%242.56M
12.58%243.04M
30.77%258.05M
32.14%260.02M
24.82%218.27M
12.01%215.89M
-4.76%197.33M
-4.75%196.78M
Total liabilities
4.58%916.83M
4.13%865.15M
18.75%887.11M
11.27%798.47M
38.27%876.67M
24.66%830.87M
15.90%747.02M
12.71%717.59M
-4.01%634.03M
-3.11%666.5M
Shareholders equity
Paid-in capital
-1.02%229.45M
-1.03%229.41M
-0.19%231.54M
-0.21%231.49M
39.87%231.81M
39.86%231.79M
39.82%231.98M
41.40%231.97M
41.46%165.73M
41.45%165.72M
Other equity instruments
-0.49%20.22M
-0.40%20.27M
-0.43%20.27M
-0.24%20.32M
-1.05%20.32M
-1.00%20.35M
-1.13%20.36M
-13.24%20.37M
-12.65%20.54M
-12.60%20.55M
Capital reserve funds
-8.76%173.52M
-8.43%173.21M
-4.34%180.08M
-3.89%179.72M
-23.58%190.19M
-23.52%189.16M
-22.94%188.25M
-15.25%187M
-6.46%248.87M
-5.48%247.34M
Surplus reserve funds
11.76%94.01M
10.80%94.01M
10.80%94.01M
11.76%94.01M
14.15%84.12M
15.14%84.85M
15.14%84.85M
14.57%84.12M
16.46%73.69M
16.46%73.69M
Retained profit
5.19%589.4M
6.34%558.74M
6.02%559.13M
9.64%543.56M
11.56%560.29M
15.53%525.45M
17.69%527.39M
19.51%495.76M
20.74%502.24M
21.64%454.81M
Less:Treasury stock
877.92%113.71M
580.92%113.71M
599.97%123.25M
-45.81%9.54M
-40.47%11.63M
-36.94%16.7M
-36.69%17.61M
-36.69%17.61M
-35.77%19.53M
-12.90%26.48M
Other composite income
-55.32%53.76M
-55.32%53.76M
-55.32%53.76M
-55.32%53.76M
529.04%120.32M
529.04%120.32M
529.04%120.32M
529.04%120.32M
-48.44%19.13M
-48.44%19.13M
Shareholders equity without minority interests
-12.44%1.05B
-12.08%1.02B
-12.11%1.02B
-0.77%1.11B
18.28%1.2B
21.00%1.16B
22.42%1.16B
26.38%1.12B
13.22%1.01B
12.83%954.76M
Total shareholder equity
-12.44%1.05B
-12.08%1.02B
-12.11%1.02B
-0.77%1.11B
18.28%1.2B
21.00%1.16B
22.42%1.16B
26.38%1.12B
13.22%1.01B
12.83%954.76M
Total liabilityies and equity
-5.24%1.96B
-5.30%1.88B
0.00%1.9B
3.93%1.91B
25.99%2.07B
22.50%1.99B
19.77%1.9B
20.67%1.84B
5.89%1.64B
5.68%1.62B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Beijing Dahua International Accounting Firm (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -33.17%136.72M-42.84%73.19M20.57%140.61M37.32%138.24M127.52%204.57M0.31%128.04M-19.22%116.61M38.89%100.67M-8.52%89.91M-59.60%127.64M
Transactional financial assets 10.75%104.48K-2.51%98.39K4.86%110.06K-15.45%94.34K--94.34K-99.33%100.93K--104.96K-99.86%111.58K-----25.00%15M
Notes receivable and accounts receivable 11.87%326.52M-9.30%298.16M-6.06%221.15M-4.03%240.36M-13.38%291.87M27.60%328.72M4.41%235.41M5.88%250.46M23.95%336.95M14.97%257.62M
-Notes receivable -62.97%5.36M-59.20%4.64M-35.68%7.35M-20.37%13.91M-34.44%14.46M-25.61%11.36M59.11%11.43M26.91%17.47M33.66%22.06M-8.98%15.27M
-Accounts receivable 15.78%321.17M-7.51%293.52M-4.54%213.8M-2.81%226.45M-11.90%277.41M30.95%317.36M2.61%223.98M4.58%232.99M23.32%314.89M16.90%242.35M
Other receivables (including interest and dividends) -52.34%35.41M-1.47%36.41M-2.95%52.7M11.51%46.6M152.20%74.3M42.57%36.96M53.50%54.3M106.37%41.79M52.00%29.46M58.45%25.92M
-Other receivable -----1.47%36.41M------------42.57%36.96M------41.79M----58.45%25.92M
Advance payment -71.86%3.39M-53.20%6.01M-43.50%7.46M-36.68%9.6M-16.73%12.03M5.40%12.84M4.51%13.21M33.98%15.16M28.35%14.45M30.62%12.18M
Inventories -12.54%148.97M-7.39%165.09M-8.76%192.23M0.54%184.33M13.45%170.33M6.66%178.26M36.35%210.69M54.37%183.34M64.04%150.13M62.10%167.14M
Receivable financing -56.07%8.27M-51.54%4.76M--3.65M-11.50%10.18M30.21%18.83M2.90%9.83M--0-75.09%11.5M-52.81%14.46M-68.65%9.55M
Other current assets 33.99%2.8M-54.35%2.1M-32.27%5.72M-7.75%7.02M1,401.25%2.09M1,201.12%4.59M42.85%8.45M489.11%7.61M-82.00%139.31K-77.03%353.06K
Total current assets -14.46%662.18M-16.23%585.83M-2.37%623.64M4.22%636.43M21.81%774.11M13.64%699.34M6.07%638.78M4.06%610.65M-2.78%635.5M-14.62%615.4M
Non Current assets
Other equity investment -16.96%383.25M-16.96%383.25M-16.96%383.25M-16.96%383.25M47.69%461.55M47.69%461.55M47.69%461.55M47.69%461.55M-6.34%312.5M23.20%312.5M
Other non-current financial assets -5.17%23.57K-5.17%23.57K-7.18%23.57K-7.18%23.57K--24.85K--24.85K--25.39K--25.39K--------
Investment real estate -2.67%3.43M-2.65%3.46M-2.64%3.48M-2.62%3.5M-2.60%3.53M-32.63%3.55M-2.81%3.58M-2.88%3.6M-2.95%3.62M40.24%5.27M
Fixed assets ----80.40%651.31M-------------0.73%361.03M------357.81M----18.18%363.7M
Constru in process -----80.82%52.32M------------75.05%272.82M------228.36M----81.48%155.85M
Intangible assets -2.86%81.05M-2.68%81.96M-2.89%82.68M-3.00%83.52M-3.87%83.44M-2.04%84.22M-1.81%85.13M-1.61%86.1M-1.57%86.79M-3.42%85.97M
Development expenditure 24.52%96.96M22.97%91.11M30.40%90.58M29.31%81.52M28.77%77.87M31.97%74.1M30.65%69.46M25.64%63.05M23.95%60.47M23.85%56.15M
Long deferred expense -21.54%5.71M-12.36%6.12M-7.03%6.52M-5.69%6.92M-5.04%7.28M-11.26%6.98M-14.29%7.01M-13.58%7.34M-14.18%7.67M-16.42%7.87M
Deferred tax assets -16.54%10.94M-32.34%10.65M-28.74%11.21M-23.27%10.33M7.44%13.11M26.00%15.74M37.85%15.74M19.53%13.46M7.53%12.2M9.71%12.49M
Usufruct assets 40.62%13.57M119.81%14.8M76.96%12.66M81.08%13.72M66.52%9.65M11.37%6.73M13.33%7.15M15.14%7.57M-15.33%5.79M-14.95%6.05M
Total non current assets 0.26%1.3B0.64%1.3B1.21%1.28B3.78%1.28B28.61%1.3B27.93%1.29B28.14%1.26B31.07%1.23B12.19%1.01B23.68%1.01B
Total assets -5.24%1.96B-5.30%1.88B0.00%1.9B3.93%1.91B25.99%2.07B22.50%1.99B19.77%1.9B20.67%1.84B5.89%1.64B5.68%1.62B
Liabilities
Current liabilities
Short term loan 4.39%452M23.28%479.43M27.13%480M15.62%366.93M68.48%433M37.77%388.9M22.58%377.55M18.27%317.37M-10.76%257M-12.30%282.27M
Notes payable and accounts payable -18.43%72.23M-11.96%73.27M-8.00%80.38M9.84%105.08M40.74%88.55M14.98%83.21M7.61%87.37M47.42%95.67M15.40%62.92M26.69%72.37M
-Notes payable ------------------8.11M--8.11M----------------
-Accounts payable -10.21%72.23M-2.45%73.27M-8.00%80.38M9.84%105.08M27.85%80.44M3.77%75.1M7.61%87.37M47.42%95.67M15.40%62.92M26.69%72.37M
Contract liabilities -83.67%543.97K-90.95%892.19K-94.89%489.93K-92.78%1M-68.64%3.33M261.69%9.86M482.43%9.59M-9.76%13.86M-1.64%10.62M-63.71%2.73M
Salaries payable 0.79%14.08M8.36%11.38M80.05%10.43M-29.83%12.43M20.11%13.97M1.01%10.51M-51.28%5.79M3.26%17.71M9.98%11.63M-5.55%10.4M
Taxs payable 3.17%25.95M24.47%24.37M-4.16%12.61M0.17%8.89M2.71%25.15M17.19%19.58M-31.59%13.15M-54.67%8.87M25.27%24.49M35.10%16.71M
Other payable (including interest and dividends) -51.29%11.23M-49.43%16.25M6.64%29.92M-21.99%30.79M-67.08%23.06M-62.20%32.12M-41.15%28.05M-32.25%39.47M4.06%70.04M25.25%84.99M
-Dividend payable ------------------------------------41.90%19.89M
-Other payable -----49.43%16.25M-------------50.65%32.12M------39.47M----20.91%65.1M
Non current liabilities due within one year 2.89%32.43M25.67%33.36M509.11%30.46M371.28%30.18M--31.51M--26.55M--5M--6.4M--------
Other current liabilities 65.47%70.72K-6.99%115.99K-88.19%264.95K-94.45%130.13K401.34%42.74K-49.77%124.7K4,210.30%2.24M572.16%2.34M-94.34%8.52K-76.88%248.27K
Total current liabilities -1.63%608.53M11.95%639.06M21.90%644.54M10.71%555.42M41.66%618.62M21.53%570.85M12.58%528.75M13.01%501.69M-3.67%436.7M-2.40%469.72M
Current liabilities
Long term loan 96.34%109.95M-53.39%28M160.00%52M159.99%52.06M124.00%56M140.01%60.07M300.00%20M299.97%20.02M84.90%25M79.83%25.03M
Bonds payable 3.12%148.89M3.19%147.17M3.32%143.13M5.00%143.48M6.70%144.39M6.45%142.62M4.31%138.53M-8.77%136.66M-9.70%135.32M-9.65%133.98M
Long term account payable -----83.06%562.7K-------------1.42%3.32M------3.36M-----2.10%3.37M
Deferred tax liabilities -38.32%17.58M-38.34%17.39M-33.38%18.7M-40.24%16.72M458.93%28.49M463.20%28.2M731.78%28.08M729.21%27.99M-22.13%5.1M-23.52%5.01M
Long term deferred income 10.63%23.49M14.29%23.85M-5.76%20.27M-5.93%20.83M-5.65%21.23M-9.87%20.87M-9.85%21.51M-9.65%22.15M-16.70%22.5M-15.43%23.15M
Lease liabilities 6.76%7.84M84.23%9.12M15.70%7.9M63.52%9.35M21.42%7.34M-20.72%4.95M5.87%6.83M-13.99%5.72M-11.59%6.05M-11.15%6.24M
Total non current liabilities 19.47%308.3M-13.05%226.09M11.13%242.56M12.58%243.04M30.77%258.05M32.14%260.02M24.82%218.27M12.01%215.89M-4.76%197.33M-4.75%196.78M
Total liabilities 4.58%916.83M4.13%865.15M18.75%887.11M11.27%798.47M38.27%876.67M24.66%830.87M15.90%747.02M12.71%717.59M-4.01%634.03M-3.11%666.5M
Shareholders equity
Paid-in capital -1.02%229.45M-1.03%229.41M-0.19%231.54M-0.21%231.49M39.87%231.81M39.86%231.79M39.82%231.98M41.40%231.97M41.46%165.73M41.45%165.72M
Other equity instruments -0.49%20.22M-0.40%20.27M-0.43%20.27M-0.24%20.32M-1.05%20.32M-1.00%20.35M-1.13%20.36M-13.24%20.37M-12.65%20.54M-12.60%20.55M
Capital reserve funds -8.76%173.52M-8.43%173.21M-4.34%180.08M-3.89%179.72M-23.58%190.19M-23.52%189.16M-22.94%188.25M-15.25%187M-6.46%248.87M-5.48%247.34M
Surplus reserve funds 11.76%94.01M10.80%94.01M10.80%94.01M11.76%94.01M14.15%84.12M15.14%84.85M15.14%84.85M14.57%84.12M16.46%73.69M16.46%73.69M
Retained profit 5.19%589.4M6.34%558.74M6.02%559.13M9.64%543.56M11.56%560.29M15.53%525.45M17.69%527.39M19.51%495.76M20.74%502.24M21.64%454.81M
Less:Treasury stock 877.92%113.71M580.92%113.71M599.97%123.25M-45.81%9.54M-40.47%11.63M-36.94%16.7M-36.69%17.61M-36.69%17.61M-35.77%19.53M-12.90%26.48M
Other composite income -55.32%53.76M-55.32%53.76M-55.32%53.76M-55.32%53.76M529.04%120.32M529.04%120.32M529.04%120.32M529.04%120.32M-48.44%19.13M-48.44%19.13M
Shareholders equity without minority interests -12.44%1.05B-12.08%1.02B-12.11%1.02B-0.77%1.11B18.28%1.2B21.00%1.16B22.42%1.16B26.38%1.12B13.22%1.01B12.83%954.76M
Total shareholder equity -12.44%1.05B-12.08%1.02B-12.11%1.02B-0.77%1.11B18.28%1.2B21.00%1.16B22.42%1.16B26.38%1.12B13.22%1.01B12.83%954.76M
Total liabilityies and equity -5.24%1.96B-5.30%1.88B0.00%1.9B3.93%1.91B25.99%2.07B22.50%1.99B19.77%1.9B20.67%1.84B5.89%1.64B5.68%1.62B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Beijing Dahua International Accounting Firm (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday+1.79%
Traditional Chinese Medicine Concept
Traditional Chinese Medicine Concept
Intraday+1.64%
Virus Prevention
Virus Prevention
Intraday+0.91%